EG24668A - Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing them - Google Patents
Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- EG24668A EG24668A EGNA2005000691A EG24668A EG 24668 A EG24668 A EG 24668A EG NA2005000691 A EGNA2005000691 A EG NA2005000691A EG 24668 A EG24668 A EG 24668A
- Authority
- EG
- Egypt
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- cyclic amine
- amine derivatives
- Prior art date
Links
- -1 Cyclic amine Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0310724.0A GB0310724D0 (en) | 2003-05-09 | 2003-05-09 | Chemical compounds |
| PCT/EP2004/005005 WO2004099143A1 (en) | 2003-05-09 | 2004-05-07 | Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG24668A true EG24668A (en) | 2010-04-11 |
Family
ID=9957781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EGNA2005000691 EG24668A (en) | 2003-05-09 | 2005-10-29 | Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070073061A1 (is) |
| EP (1) | EP1622871A1 (is) |
| JP (1) | JP4684221B2 (is) |
| KR (1) | KR20060009313A (is) |
| CN (1) | CN100534983C (is) |
| AR (1) | AR044269A1 (is) |
| AU (1) | AU2004235967B2 (is) |
| BR (1) | BRPI0410154A (is) |
| CA (1) | CA2524894A1 (is) |
| EG (1) | EG24668A (is) |
| GB (1) | GB0310724D0 (is) |
| IS (1) | IS8164A (is) |
| MA (1) | MA27795A1 (is) |
| MX (1) | MXPA05012096A (is) |
| MY (1) | MY140027A (is) |
| NO (1) | NO20055835L (is) |
| NZ (1) | NZ543068A (is) |
| RU (1) | RU2392270C2 (is) |
| TW (1) | TWI332499B (is) |
| WO (1) | WO2004099143A1 (is) |
| ZA (1) | ZA200508339B (is) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412865D0 (en) | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
| US7844037B2 (en) | 2005-08-08 | 2010-11-30 | Palm, Inc. | Method and device for enabling message responses to incoming phone calls |
| EP2094692B1 (en) | 2006-11-01 | 2012-11-28 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| CN102131779A (zh) * | 2008-09-01 | 2011-07-20 | 神经研究公司 | 哌啶-4-乙酰胺衍生物及其作为单胺神经递质再摄取抑制剂的应用 |
| WO2013004766A1 (en) | 2011-07-04 | 2013-01-10 | Ferrari Giulio | Nk-1 receptor antagonists for treating corneal neovascularisation |
| CN106187999A (zh) * | 2015-05-04 | 2016-12-07 | 复旦大学 | 取代哌啶类化合物及其制备方法和用途 |
| JP2024511204A (ja) | 2021-03-23 | 2024-03-12 | バイオエイジ ラブス, インコーポレイテッド | Nlrp3インフラマソームの阻害剤 |
| CN119053602A (zh) | 2022-01-28 | 2024-11-29 | 柏奥艾奇实验室公司 | Nlrp3炎性体的n-氧化物抑制剂 |
| US12509459B2 (en) | 2024-03-26 | 2025-12-30 | BioAge Labs, Inc. | Inhibitors of NLRP3 inflammasome |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US309720A (en) * | 1884-12-23 | William p | ||
| NL130088C (is) * | 1960-03-14 | |||
| GB1356117A (en) * | 1970-12-16 | 1974-06-12 | Searle & Co | 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives |
| US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| DE19603767A1 (de) * | 1996-02-02 | 1997-08-07 | Hoechst Ag | Pyrrolidinpropionsäurederivate mit bradykinin-antagonistischer Wirkung |
| US6034136A (en) * | 1997-03-20 | 2000-03-07 | Novartis Ag | Certain cyclic thio substituted acylaminoacid amide derivatives |
| AU1415099A (en) * | 1997-11-18 | 1999-06-07 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
| PE20021081A1 (es) * | 2001-04-12 | 2002-12-18 | Pharmacopeia Drug Discovery | Aril y biaril piperidinas con actividad moduladora mch |
| IL161717A0 (en) * | 2001-11-26 | 2004-09-27 | Schering Corp | Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| DE60330794D1 (de) * | 2002-07-03 | 2010-02-11 | Glaxo Group Ltd | Substituierte 4-phenylpiperidinamide als tachykininantagonisten und serotoninwiederaufnahmehemmer |
-
2003
- 2003-05-09 GB GBGB0310724.0A patent/GB0310724D0/en not_active Ceased
-
2004
- 2004-05-07 AR ARP040101565A patent/AR044269A1/es not_active Application Discontinuation
- 2004-05-07 US US10/554,822 patent/US20070073061A1/en not_active Abandoned
- 2004-05-07 NZ NZ543068A patent/NZ543068A/xx unknown
- 2004-05-07 MY MYPI20041688A patent/MY140027A/en unknown
- 2004-05-07 JP JP2006505412A patent/JP4684221B2/ja not_active Expired - Fee Related
- 2004-05-07 AU AU2004235967A patent/AU2004235967B2/en not_active Ceased
- 2004-05-07 EP EP04731635A patent/EP1622871A1/en not_active Withdrawn
- 2004-05-07 RU RU2005138315/04A patent/RU2392270C2/ru not_active IP Right Cessation
- 2004-05-07 MX MXPA05012096A patent/MXPA05012096A/es active IP Right Grant
- 2004-05-07 BR BRPI0410154-5A patent/BRPI0410154A/pt not_active IP Right Cessation
- 2004-05-07 CA CA002524894A patent/CA2524894A1/en not_active Abandoned
- 2004-05-07 TW TW093112840A patent/TWI332499B/zh not_active IP Right Cessation
- 2004-05-07 WO PCT/EP2004/005005 patent/WO2004099143A1/en not_active Ceased
- 2004-05-07 KR KR1020057021196A patent/KR20060009313A/ko not_active Abandoned
- 2004-05-07 CN CNB2004800194957A patent/CN100534983C/zh not_active Expired - Fee Related
-
2005
- 2005-10-14 ZA ZA200508339A patent/ZA200508339B/en unknown
- 2005-10-29 EG EGNA2005000691 patent/EG24668A/xx active
- 2005-11-08 MA MA28584A patent/MA27795A1/fr unknown
- 2005-12-01 IS IS8164A patent/IS8164A/is unknown
- 2005-12-08 NO NO20055835A patent/NO20055835L/no unknown
-
2007
- 2007-10-10 US US11/869,945 patent/US20090192194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060009313A (ko) | 2006-01-31 |
| MA27795A1 (fr) | 2006-03-01 |
| IS8164A (is) | 2005-12-01 |
| US20090192194A1 (en) | 2009-07-30 |
| MXPA05012096A (es) | 2006-02-08 |
| MY140027A (en) | 2009-11-30 |
| NZ543068A (en) | 2009-07-31 |
| NO20055835D0 (no) | 2005-12-08 |
| JP2006525975A (ja) | 2006-11-16 |
| CA2524894A1 (en) | 2004-11-18 |
| AU2004235967A1 (en) | 2004-11-18 |
| ZA200508339B (en) | 2006-10-25 |
| RU2392270C2 (ru) | 2010-06-20 |
| AR044269A1 (es) | 2005-09-07 |
| EP1622871A1 (en) | 2006-02-08 |
| WO2004099143A1 (en) | 2004-11-18 |
| AU2004235967B2 (en) | 2008-10-23 |
| CN100534983C (zh) | 2009-09-02 |
| RU2005138315A (ru) | 2007-06-20 |
| JP4684221B2 (ja) | 2011-05-18 |
| US20070073061A1 (en) | 2007-03-29 |
| NO20055835L (no) | 2006-02-07 |
| GB0310724D0 (en) | 2003-06-11 |
| CN1819995A (zh) | 2006-08-16 |
| TWI332499B (en) | 2010-11-01 |
| BRPI0410154A (pt) | 2006-05-16 |
| TW200510309A (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL175614A0 (en) | Cyclic amine derivatives having a heteroaryl ring and pharmaceutical compositions containing the same | |
| IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| HUP0400048A3 (en) | N-aroyl cyclic amines and pharmaceutical compositions containing them | |
| IL169818A0 (en) | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them | |
| IL164185A0 (en) | Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives | |
| IL187524A0 (en) | Cyclic amine derivatives having a substituted alkyl group and pharmaceutical compositions containing the same | |
| IL173195A0 (en) | Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them | |
| IL169500A0 (en) | Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL183105A0 (en) | 4-arylamino pyridone derivatives and pharmaceutical compositions containing them | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| HUP0200438A3 (en) | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| SI1720544T1 (sl) | Novi azabicikliäśni derivati, postopek za njihovopripravo in farmacevtski sestavki, ki jih vsebujejo | |
| PL1601363T3 (pl) | Zastosowanie pochodnych cholest-4-en-onu jako leków, kompozycje farmaceutyczne zawierające te pochodne, nowe pochodne i sposób ich wytwarzania | |
| IL172338A0 (en) | Cyclic tertiary amine compounds and pharmaceutical compositions containing the same | |
| IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
| PL375373A1 (en) | Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same | |
| IL175498A0 (en) | Pharmaceutical compositions containing n-hydroxypiperidine derivatives | |
| IL174135A0 (en) | Benzimidazole acetonitrile derivatives, their preparation and and pharmaceutical compositions containing them | |
| IL163643A0 (en) | Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them | |
| EG24668A (en) | Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing them | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| PT1590314E (pt) | Ácidos 2-aril-acéticos, seus derivados e composições farmacêuticas que os contêm | |
| IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
| IL174252A0 (en) | Benzoxazole acetonitrile derivatives, their preparation and pharmaceutical compositions containing them | |
| SI1241169T1 (en) | Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them |